Profile
ABEO NVO VRTX REGN MRNA SGEN
Company Name Abeona Therapeutics Inc. Novo Nordisk A/S Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Moderna, Inc. Seagen Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $166.49M $564.36B $109.10B $105.53B $44.96B $43.15B
Employees 0.08K 66.02K 5.40K 13.68K 5.60K 3.26K
CEO Dr. Vishwas Seshadri M.B.A., Ph.D. Mr. Lars Fruergaard Jorgensen Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. Stephane Bancel Mr. David R. Epstein B.Sc., M.B.A.
Ratings
ABEO NVO VRTX REGN MRNA SGEN
Quant Rating Score 2 5 5 5 2 3
Quant Rating Sell Strong Buy Strong Buy Strong Buy Sell Neutral
Trading
ABEO NVO VRTX REGN MRNA SGEN
Last Close $4.2 $128.42 $422.78 $973.8 $117.31 $228.74
High 52 $8.68 $199.54 $446.08 $993.35 $137.75 $228.9
Low 52 $2.96 $87.78 $323.57 $692.45 $69.51 $187.64
Price vs. 52 Week High -51.61 % -35.64 % -5.22 % -1.97 % -14.84 % -0.07 %
Price vs. 52 Week Low 41.89 % 46.3 % 30.66 % 40.63 % 68.77 % 21.9 %
Total Return
ABEO NVO VRTX REGN MRNA SGEN
1 Month Return -44.37 % 3.14 % 6.61 % 7.64 % 11.58 % 0 %
3 Month Return -35.19 % 6.55 % 1.02 % 2.82 % 31.81 % 0 %
6 Month Return 2.69 % 26.91 % 13.15 % 21.89 % 67.47 % 7.03 %
9 Month Return 40.47 % -29.28 % 20.84 % 20.68 % 15.59 % 17.5 %
YTD Return -16.17 % 24.14 % 3.91 % 10.87 % 17.96 % 0 %
1 Year Return 41.41 % -25.02 % 21.69 % 30.83 % -9.27 % 14.94 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ABEO NVO VRTX REGN MRNA SGEN
Dividend Yield Percentage (TTM) - 0.16 % - - - -
Dividend Paid and Capex Coverage Ration (TTM) -111.81 % 1.1 % 8.49 % 6.2 % -3.65 % -3.35 %
Dividend Per Share (TTM) - 0.2 % - - - -
Payout Ratio (TTM) - 47.03 % - - - -
Growth
ABEO NVO VRTX REGN MRNA SGEN
Asset Growth -0.33 % 30.35 % 25.23 % 13.23 % -28.74 % -1.21 %
Gross Profit Growth -68.67 % 32.32 % 9.25 % 6.49 % -85.12 % 22.93 %
Revenue Growth 147.52 % 31.26 % 10.17 % 7.76 % -64.94 % 24.65 %
Revenue 3 Year -93.93 % 90.51 % 59.87 % 55.67 % 2356.27 % 91.84 %
Revenue 5 Year -89.62 % 124.2 % 218.58 % 110.3 % 1070.62 % 215.48 %
Revenue 10 Year -99.84 % 66.11 % 608.27 % 549.62 % 6447.35 % 494.04 %
EBIT Growth -6.5 % 37.11 % -12.94 % -14.6 % -145 % 10.13 %
Net Income Growth -70.35 % 50.71 % 8.96 % -8.87 % -156.37 % 9.51 %
Net Income 3 Yeari Growth Per Share 89.37 % 106.79 % 34.59 % 13.48 % -529.9 % -764.83 %
Net Income 5 Yeari Growth Per Share 91.5 % 133.86 % 70.33 % 74.02 % -160.17 % -276.93 %
Net Income 10 Yeari Growth Per Share -101.15 % 98.61 % 809.6 % 871.12 % -2046.03 % -624.16 %
Operating Income Growth -6.5 % 37.11 % -12.94 % -14.6 % -145 % 10.13 %
Operating Cash Flow Growth (CFG) 14.89 % 38.06 % -14.35 % -8.39 % -162.6 % 9.07 %
Operating 3 Year CFG 81.68 % 118.29 % 9.63 % 76.95 % -253.56 % -148.34 %
Operating 5 Year CFG 91.59 % 163.51 % 174.78 % 125.17 % -100.11 % -195.86 %
Operating 10 Year CFG -3595.52 % 150.92 % 5187.08 % 713.56 % -4698.89 % -2622.09 %
EPS Growth 37.53 % 52.28 % 8.33 % -8.54 % -158.15 % 10.81 %
EPS Diluted Growth 37.53 % 52.37 % 8.35 % -9.03 % -161.39 % 10.81 %
Book Value Per Share -79.63 % 29 % 25.58 % 15.03 % -25.28 % -9.83 %
Share Holder 3 Year Equity Growth Per Share -97.49 % 75.22 % 104.06 % 137.56 % 439.94 % 33.92 %
Share Holder 5 Year Equity Growth Per Share -99.02 % 121.9 % 291.14 % 219.1 % 92.24 % 220.81 %
Share Holder 10 Year Equity Growth Per Share 100.09 % 49.62 % 1030.79 % 1286.9 % 1519.81 % 691.19 %
Dividend Per Share Growth - 26.89 % - - - -
Dividend 3 Year Growth Per Share - 64.4 % - - - -
Dividend 5 Year Growth Per Share - - - - - -
Dividend 10 Year Growth Per Share - 95.44 % - - - -
Debt Growth -29.2 % 4.74 % 44.1 % 0.06 % 3.58 % -23.28 %
Free Cash Flow Growth 14.38 % 9.17 % -16.47 % -17.11 % -183.5 % 3.67 %
Updated On 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2022
Profitability
ABEO NVO VRTX REGN MRNA SGEN
Gross Profit Margin TTM 8.63 % 84.65 % 86.86 % 87.16 % 21.77 % 75.4 %
Return on Assets TTM -84.67 % 29.87 % 16.81 % 11.22 % -35.67 % -20.64 %
Return on Equity TTM -333.73 % 91.82 % 23.61 % 15.15 % -41.83 % -28.06 %
Return on Capital Employed TTM -95.29 % 82.5 % 20.67 % 12.53 % -35.81 % -29.5 %
Net Income Per EBT TTM 100 % 79.81 % 84.31 % 95.44 % 124.28 % 101.53 %
EBT Per Ebit TTM 112.42 % 101.7 % 114.62 % 104.74 % 93.44 % 93.47 %
EBIT Per Revenue TTM -1377.14 % 45.03 % 40.85 % 29.46 % -99.69 % -34.37 %
Cash Flow To Debt Ratio TTM -685.35 % 346.88 % 546.79 % 238.94 % -232.98 % -475.96 %
Receivables Turnover TTM 1.43 3.87 5.68 2.51 13.32 3.64
Payables Turnover TTM 1.72 2.88 3.81 2.51 22.04 2.52
Inventory Turnover TTM - 1.12 1.65 0.62 13.67 1.07
Fixed Asset Turnover TTM 43.82 % 248.64 % 685.31 % 310.02 % 186.78 % 471.71 %
Asset Turnover TTM 5.47 % 81.71 % 42.57 % 38.12 % 30.81 % 63.3 %
Operating Cash Flow Per Share TTM -1.45 20.95 15.27 43.96 -7.54 -2.87
Free Cash Flow Per Share TTM -1.46 11.28 13.48 36.87 -9.61 -3.73
Cash Per Share TTM 205.68 % 208.61 % 3939.31 % 9758.35 % 2235.6 % 657.5 %
Operating Cash Flow Sales Ratio TTM -1057.4 % 38.24 % 38.74 % 36.17 % -55.91 % -23.48 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.89 % 53.85 % 88.22 % 83.87 % 127.41 % 129.82 %
Cash Flow Coverage Ratios TTM -685.35 % 346.88 % 546.79 % 238.94 % -232.98 % -475.96 %
Price To Free Cash Flows Ratio TTM -4.46 77.7 31.36 26.55 -12.24 -61.54
Price To Operating Cash Flows Ratio TTM -2.9 42.47 27.68 22.15 -15.55 -79.67
Price Cash Flow Ratio TTM -2.9 42.47 27.68 22.15 -15.55 -79.67
Income Statement (TTM)
ABEO NVO VRTX REGN MRNA SGEN
Revenue $0B $232.26B $9.84B $13.12B $6.75B $1.96B
Gross Profit $0B $196.5B $8.58B $11.3B $2.06B $1.55B
Gross Profit Ratio 8.63% 84.6% 87.17% 86.16% 30.52% 79.1%
EBITDA $-0.05B $112.94B $3.93B $5.13B $-3.21B $-0.62B
Net Income $-0.05B $83.68B $3.62B $3.95B $-4.71B $-0.61B
EPS Diluted -2.53 18.62 13.89 34.77 -12.34 -3.3
Balance Sheet (MRQ)
ABEO NVO VRTX REGN MRNA SGEN
Long Term Debt $0B $20.53B $0.72B $2.7B $1.22B $0.04B
Total Liabilities $0.05B $207.93B $5.15B $7.11B $4.57B $0.87B
Total Equity $0.01B $106.56B $17.58B $25.97B $13.85B $2.8B
Total Investments $0.04B $17.5B $3.45B $13.51B $4.68B $1.42B
Total Debt $0.01B $27.01B $0.81B $2.7B $1.24B $0.04B
Total Assets $0.06B $314.49B $22.73B $33.08B $18.43B $3.67B
Cash Flow Statement (TTM)
ABEO NVO VRTX REGN MRNA SGEN
Net Income $-0.05B $83.68B $3.62B $3.95B $-4.71B $-0.61B
Inventory $0B $-7.42B $-0.32B $-0.27B $0.75B $-0.23B
Dividends Paid $0B $-31.77B $0B $0B $0B $0B
Operating Cash Flow $-0.04B $108.91B $3.54B $4.59B $-3.12B $-0.45B
Capital Expenditure $-0B $-38.9B $-0.26B $-0.93B $-0.71B $-0.08B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 1.78
ABCL AbCellera Biologics Inc. 3.83
ABCM Abcam plc 23.99
ABIO ARCA biopharma, Inc. 3.47
ABOS Acumen Pharmaceuticals, Inc. 3.36
ABSI Absci Corporation 4.91
ABUS Arbutus Biopharma Corporation 2.88
ABVC ABVC BioPharma, Inc. 1.06
ABVX Abivax SA American Depositary Shares 14.09
ACAD ACADIA Pharmaceuticals Inc. 15.25
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 1.47
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 0.9401
ACHV Achieve Life Sciences, Inc. 4.61
ACIU AC Immune SA 2.31
ACLX Arcellx, Inc. 49.74
ACRV Acrivon Therapeutics, Inc. Common Stock 8.77
ACST Acasti Pharma Inc. 2.76
ACXP Acurx Pharmaceuticals, Inc. 2.03
ETFs With Exposure to ABEO
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 258.05
ITOT iShares Core S&P Total U.S. Stock Market ETF 0.00036 114.52
VXF Vanguard Extended Market Index Fund 0 170.59
IWC iShares Micro-Cap ETF 0.01821 117.129
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 89.47
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 89.45
VBAIX Vanguard Balanced Index Fund Institutional Shares 0 46.27
VBIAX Vanguard Balanced Index Fund Admiral Shares 0 46.27
VBINX Vanguard Balanced Index Fund Investor Shares 0 46.27
IEIH iShares Evolved U.S. Innovative Healthcare ETF 0 34.1348
DFAT Dimensional U.S. Targeted Value ETF 0 53.58
DFAS Dimensional U.S. Small Cap ETF 0.00021364 61.34
DFAC Dimensional U.S. Core Equity 2 ETF 0 31.62
VTSAX Vanguard Total Stock Market Index Fund 0 125.62
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 129.48
VITSX Vanguard Total Stock Market Index Fund 0 125.64
IBRN iShares Neuroscience and Healthcare ETF 0.19047 23.2733
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000276985 88.42
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 129.49
JKK iShares Morningstar Small-Cap Growth ETF 0 307.42
JKJ iShares Morningstar Small-Cap ETF 0 231.193
JKL iShares Morningstar Small-Cap Value ETF 0 172.726
SURI Simplify Propel Opportunities ETF 0.037798 22.0979
VEMPX Vanguard Extended Market Index InstlPlus 0 319.54
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 235.66
Unlock